Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

SNTI

Senti Biosciences (SNTI)

Senti Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SNTI
FechaHoraFuenteTítuloSímboloCompañía
29/05/202415:14Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:SNTISenti Biosciences Inc
29/05/202415:09Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SNTISenti Biosciences Inc
29/05/202415:07Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SNTISenti Biosciences Inc
17/05/202416:19Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SNTISenti Biosciences Inc
17/05/202416:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNTISenti Biosciences Inc
13/05/202407:15GlobeNewswire Inc.Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid LeukemiaNASDAQ:SNTISenti Biosciences Inc
09/05/202415:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNTISenti Biosciences Inc
09/05/202415:05GlobeNewswire Inc.Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate HighlightsNASDAQ:SNTISenti Biosciences Inc
30/04/202407:05GlobeNewswire Inc.Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)NASDAQ:SNTISenti Biosciences Inc
21/03/202415:05GlobeNewswire Inc.Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent HighlightsNASDAQ:SNTISenti Biosciences Inc
05/01/202415:05GlobeNewswire Inc.Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical ProgramNASDAQ:SNTISenti Biosciences Inc
22/12/202305:30GlobeNewswire Inc.Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid LeukemiaNASDAQ:SNTISenti Biosciences Inc
13/11/202315:15GlobeNewswire Inc.Senti Bio Announces Third Quarter 2023 Results and Pipeline UpdatesNASDAQ:SNTISenti Biosciences Inc
06/11/202315:05GlobeNewswire Inc.Senti Bio Announces New Strategic Collaboration with Celest Therapeutics for Clinical Development of SENTI-301A in ChinaNASDAQ:SNTISenti Biosciences Inc
31/10/202308:06GlobeNewswire Inc.Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer Annual MeetingNASDAQ:SNTISenti Biosciences Inc
27/09/202308:05GlobeNewswire Inc.Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer 2023 MeetingNASDAQ:SNTISenti Biosciences Inc
26/09/202315:05GlobeNewswire Inc.Senti Bio to Participate in Upcoming ConferencesNASDAQ:SNTISenti Biosciences Inc
05/09/202307:30GlobeNewswire Inc.Senti Bio to Participate in Upcoming Investor ConferencesNASDAQ:SNTISenti Biosciences Inc
11/08/202307:35GlobeNewswire Inc.Senti Bio Announces Second Quarter 2023 Results and Pipeline UpdatesNASDAQ:SNTISenti Biosciences Inc
10/08/202307:35GlobeNewswire Inc.Senti Bio Announces Closing of Transaction Leveraging its CMC Capabilities into a Cell and Gene Therapy Manufacturing Innovation Business Backed by Celadon PartnersNASDAQ:SNTISenti Biosciences Inc
20/05/202307:05GlobeNewswire Inc.Senti Bio Highlights Initial Gene Circuit Data From Collaborations at the American Society of Gene and Cell Therapy (ASGCT) Annual MeetingNASDAQ:SNTISenti Biosciences Inc
09/05/202315:05GlobeNewswire Inc.Senti Bio Announces First Quarter 2023 Results and Pipeline UpdatesNASDAQ:SNTISenti Biosciences Inc
02/05/202315:45GlobeNewswire Inc.Senti Bio Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 2023 Annual MeetingNASDAQ:SNTISenti Biosciences Inc
17/04/202307:45GlobeNewswire Inc.Senti Bio Highlights Preclinical Data from Multiple Gene Circuit Enabled Cell Therapy Programs at Annual AACR MeetingNASDAQ:SNTISenti Biosciences Inc
22/03/202316:09GlobeNewswire Inc.Senti Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Reviews Recent HighlightsNASDAQ:SNTISenti Biosciences Inc
14/03/202315:35GlobeNewswire Inc.Senti Bio Announces Three Preclinical Data Presentations from Gene Circuit-Enhanced CAR-NK Cell Oncology Pipeline at Annual AACR MeetingNASDAQ:SNTISenti Biosciences Inc
03/02/202315:05GlobeNewswire Inc.Senti Biosciences Announces New Employment Inducement GrantsNASDAQ:SNTISenti Biosciences Inc
01/02/202315:05GlobeNewswire Inc.Senti Bio to Present at the SVB Securities Global Biopharma ConferenceNASDAQ:SNTISenti Biosciences Inc
27/01/202307:00GlobeNewswire Inc.Senti Bio Announces Pipeline Prioritization to Focus on Logic Gated Cell Therapies; Updates Cash Runway GuidanceNASDAQ:SNTISenti Biosciences Inc
19/12/202206:55GlobeNewswire Inc.Senti Bio to Present at 41st Annual J.P. Morgan Healthcare ConferenceNASDAQ:SNTISenti Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:SNTI

Su Consulta Reciente

Delayed Upgrade Clock